THU0402 Increased Expression of Baff Receptor on B Cells May be Implicated in Delayed Response in Sy...
THU0402 Increased Expression of Baff Receptor on B Cells May be Implicated in Delayed Response in Systemic Lupus Erythematosus Patients Under Belimumab Therapy
About this item
Full title
Author / Creator
Quartuccio, L. , De Marchi, G. , Rossi, F. , Zuliani, F. , Corazza, L. , Picco, L. , Masolini, P. , Rizzolio, F. and De Vita, S.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
More information
Scope and Contents
Contents
BackgroundTargeting B cell activating factor (BAFF) by belimumab is effective in systemic lupus erythematosus (SLE) (1), and leads to a partial B cell depletion (2,3). However, which subset of B cells may be the main therapeutic target of belimumab in SLE, either why the response under belimumab is usually delayed in time is still unclear.Objective...
Alternative Titles
Full title
THU0402 Increased Expression of Baff Receptor on B Cells May be Implicated in Delayed Response in Systemic Lupus Erythematosus Patients Under Belimumab Therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1901810041
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1901810041
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2015-eular.4046
